ComplicationsSupplements and VitaminsType 2 Diabetes (T2D)
RESEARCH SUMMARY

Curcumin plus piperine may improve sleep and mood in diabetic retinopathy

Moderate confidence
some concerns bias
Last updated May 26, 2026

Key takeaway:

In adults with non-proliferative diabetic retinopathy, 12 weeks of curcumin plus piperine improved sleep quality and mood scores and produced small reductions in BMI and waist circumference versus placebo.

Study at a glance

What was studied

A 12-week curcumin-piperine supplementation trial in non-proliferative diabetic retinopathy.

Study type

Randomized Controlled Trials (RCTs)

duration

Short-Term (≤3 mo)

Intervention

Curcumin plus piperine

Outcomes

BMI, Waist circumference, Sleep quality, Depression score, Anxiety score, Stress score

Funding

Industry sponsored

Main effects

Sleep quality score improved (PSQI ↓) versus placebo

Depression, anxiety, and stress scores improved versus placebo

BMI and waist circumference showed small favorable decreases

Evidence Summary

InterventionOutcomeMeasured ChangeStudy Effect
Supplements
Curcumin plus piperine
(Supplements)
Patient-Reported
Anxiety score
(Patient-Reported)
Decrease
Mixed
Supplements
Curcumin plus piperine
(Supplements)
Weight & Anthropometrics
BMI
(Weight & Anthropometrics)
Decrease
Limited
Supplements
Curcumin plus piperine
(Supplements)
Patient-Reported
Depression score
(Patient-Reported)
Decrease
Mixed
Supplements
Curcumin plus piperine
(Supplements)
Patient-Reported
Sleep quality
(Patient-Reported)
Decrease
Mixed
Supplements
Curcumin plus piperine
(Supplements)
Patient-Reported
Stress score
(Patient-Reported)
Decrease
Mixed
Supplements
Curcumin plus piperine
(Supplements)
Weight & Anthropometrics
Waist circumference
(Weight & Anthropometrics)
Decrease
Limited

Unlock Full Evidence Analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • Randomized, double-blind, placebo-controlled design supports internal validity.
  • Intention-to-treat analysis included all 60 randomized participants.
  • Anthropometric effects were statistically significant but small in magnitude.
who this applies

Who this applies to

Adults aged 30-65 with non-proliferative diabetic retinopathy

keep in mind

Keep in Mind

The trial duration was 12 weeks, so long-term effects are uncertain.

between the lines

Between the Lines

  • Small sample size
  • Single-center trial
  • Short follow-up duration
  • Single dose tested without dose-response analysis

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Journal Reference

Amini S, Dehghani A, Sahebkar A, et al. The Effect of Curcumin Plus Piperine on Mental Health Status, Sleep Quality, and Anthropometric Indices in Patients with Non-Proliferative Diabetic Retinopathy: A Randomized Double-Blind Placebo-Controlled Trial. Int J Prev Med. 2026;17:14. doi:10.4103/ijpvm.ijpvm_276_23

Sources

Ranked by clinical relevance and evidence quality.

Key References

Most relevant evidence and guidance related to this research.

1
Guideline

AACE Releases 2023 Type 2 Diabetes Management Algorithm to Support Clinical Decision Making | American Association of Clinical Endocrinology

This new algorithm provides concise guidance to assist health care professionals with clinical decision-making for the management of persons with type 2 diabetes mellitus and related comorbidities and complications.
2
Guideline

Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D | American Association of Clinical Endocrinology

Abaloparatide followed by alendronate treatment may improve bone mineral density (BMD) in women with postmenopausal osteoporosis and type 2 diabetes (T2D), according to study results presented at the AACE 28th Annual Scientific & Clinical Congress.
3
Guideline

Connecting the Dots: Diabetes, CKD, and CVD Pathways | American Association of Clinical Endocrinology

Connecting the Dots: Diabetes, CKD, and CVD Pathways enhances clinical understanding of the interconnected conditions of type 2 diabetes (T2D), chronic kidney disease (CKD), and cardiovascular disease (CVD). Strengthen recognition of shared pathophysiology, apply evidence-based risk assessment and treatment strategies, and improve care coordination through timely and appropriate referrals to drive better outcomes for patients with complex cardiometabolic conditions with this FREE course.

13 total sources in this category

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.